Ramirez KA, Mond J, Papenburg J, Boivin G, et al. In-vivo and human evidence for potential efficacy of therapeutic polyclonal RSV neutralizing antibodies for palivizumab-resistant RSV infections. Virology 2023;586:115-121.
PMID: 37542818